Vitrolife AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 904 million compared to SEK 855 million a year ago. Net loss was SEK 4,179 million compared to net income of SEK 74 million a year ago.

Basic loss per share from continuing operations was SEK 30.86 compared to basic earnings per share from continuing operations of SEK 0.55 a year ago.